Science Explorer Back to mapMap
Discussion
Researcher · Inserm · France

Anne‐Paule Gimenez‐Roqueplo

Anne‐Paule Gimenez‐Roqueplo publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research, on topics such as Adrenal and Paraganglionic Tumors, Cancer, Hypoxia, and Metabolism and Hormonal Regulation and Hypertension.

ORCID 0000-0002-4816-670X OpenAlex
World rank
#22,173
of 7,710,434 ranked researchers
Rank in France
#3,499
of 324,115
Works
393
Citations
63k
Citations per work
161.0
h-index
97
i10-index 220Top 0.3% in Endocrinology, Diabetes and Metabolism
Anne‐Paule Gimenez‐Roqueplo

What does Anne‐Paule Gimenez‐Roqueplo research?

Anne‐Paule Gimenez‐Roqueplo's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (25%).

Health Sciences: 225 works · 57.3% of their workMedicine: 225 works · 57.3% of their workEndocrinology, Diabetes and Metabolism: 108 works · 27.5% of their workSurgery: 84 works · 21.5% of their workPulmonary and Respiratory Medicine: 18 works · 4.6% of their workNeurology: 15 works · 3.7% of their workLife Sciences: 100 works · 25.4% of their workBiochemistry, Genetics and Molecular Biology: 100 works · 25.4% of their workCancer Research: 66 works · 16.8% of their workMolecular Biology: 34 works · 8.6% of their workEverything else: 68 works · 17.3% of their workTHEIR WORKAnne‐PauleGimenez‐Roqueplo393works
Life Sciences25%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine22557.3%
    1. Biochemistry, Genetics and Molecular Biology10025.4%
  3. Everything else6817.3%
  1. 1Endocrinology, Diabetes and Metabolism28% of their works
  2. 2Surgery22% of their works
  3. 3Cancer Research17% of their works
  4. 4Molecular Biology9% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Anne‐Paule Gimenez‐Roqueplo's research?

The keywords of their largest research topics: Genetic Mutations, Molecular Classification, Paraganglioma, Pheochromocytoma, HIF-1, Warburg Effect, Aldosterone and Primary Aldosteronism.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Genetic Mutations2172 topics
  2. Molecular Classification2042 topics
  3. Paraganglioma1911 topic
  4. Pheochromocytoma1911 topic
  5. HIF-11221 topic
  6. Warburg Effect1221 topic
  7. Aldosterone1211 topic
  8. Primary Aldosteronism1211 topic
  9. Cushing's Syndrome1091 topic
  10. Pituitary Adenomas1091 topic
  11. Immunotherapy392 topics
  12. ALK261 topic
  13. Neuroblastoma261 topic
  14. Cancer Genomics251 topic
  15. Mutational Signatures251 topic
  16. Differentiated Thyroid Cancer181 topic
  17. Thyroid Nodules181 topic
  18. Glioblastoma131 topic
  19. Temozolomide131 topic

Where does Anne‐Paule Gimenez‐Roqueplo work?

Anne‐Paule Gimenez‐Roqueplo's main affiliation in the publication record is Inserm, France.

How many publications and citations does Anne‐Paule Gimenez‐Roqueplo have?

OpenAlex counts 393 works and 63,275 citations for Anne‐Paule Gimenez‐Roqueplo, an h-index of 97, ranking #22,173 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anne‐Paule Gimenez‐Roqueplo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.